ATOSSA THERAPEUTICS, INC. — Director's Dealing 2023

Jun 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA THERAPEUTICS, INC. (ATOS)
CIK: 0001488039
Period of Report: 2023-06-01

Reporting Person: WEAVER GREGORY L (Director, EVP & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Stock Option (right to buy)	$0.92	A	2600000	Acquired	2033-06-01	Common Stock (2600000)	Direct

Footnotes

F1: The options shall vest with respect to 25% on the one year anniversary of June 1, 2023, and the remainder shall vest in equal quarterly installments over the following three years, subject to the reporting person's continued service through each applicable vesting date.